Bignon et al., Genes & Development 7:1654-1662 (1993). |
Freidman, Cancer 70:1810-1817 (1992). |
Parker et al, Proc. Natl. Acad. Sci. USA 89:2917-2921 (1992). |
Bandara et al., Cyclin A and the retinoblastoma gene product complex with a common transcription factor, (1991) Nature 352:249-252. |
Chelappan et al., The E2F transcription factor is a cellular target for the RB protein, (1991) Cell 65:1053-1061. |
Cross et al., Simple and Complex cell cycles, (1989) Ann. Rev. Cell Biol. 5:341-395. |
Devoto et al., A cyclin A-Protein kinase complex possesses sequence-specific DNA binding activity:p33.sup.cdk2 is a component of the E2F-cyclin A complex, (1992) Cell 68:167-176. |
Draetta et al., cdc2 protein kinase is complexed with both cyclin A dn B: Evidence for proteolytic inactivation of MPF, (1989) Cell 56:829-838. |
Draetta, Cell cycle control in eukaryotes: Molecular mechanisms of cdc2 activation, (1990) TIBS 15:378-383. |
Draetta et al., Activation of cdc2 protein kinase during mitosis in human cells: Cell cycle-dependent phosphorylation and subunit rearrangement, (1988), Cell 54:17-26. |
Dyson et al., The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product, (1989) Science 243:934-937. |
Elledge et al., CDK2 encodes a 33-kDa cyclin A-associated protein kinase and is expressed before CDC2 in the cell cycle, (1992) Proc. Natl. Acad. Sci. USA 89:2907-2911. |
Ewen et al., Interaction of p107 with cyclin A independent of complex formation with viral oncoproteins, (1992) Science 255:85-87. |
Ewen et al., Molecular cloning, chromosomalmapping, and expression of the cDNA for p107, a retinoblastoma gene product-related protein, (1991) Cell 66:1155-1164. |
Faha et al., Interaction between human cyclin A and adenovirus E1A-associated p107 protein, (1992) Science 255: 87-90. |
Furukawa et al., CDC2 gene expression at the G.sub.1 to S transition in human T lymphocytes, (1990) Science 250:805-808. |
Gage et al., The E7 proteins of the nonnoncogenic human papillomavirus type 6b (HPV-6b) and of the oncogenic HPV-16 differ in retinoblastoma protein binding and other properties, (1990) J. Virol. 64:723-730. |
Giordano et al., A 60 kd CDC2-associated polypeptide complexes with the E1A proteins in adenovirus-infected cells, (1989) Cell 981-990. |
Gu et al., Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit, (1993) Nature 366:707-710. |
Harper et al., The p21 CDK-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases, (1993) Cell 75:805-816. |
Horowitz et al., Point mutational inactivation of the retinoblastoma antioncogene, (1989) Science 243:937-940. |
Hu et al., The regions of the retinoblastoma protein needed for binding to adenovirus E1A or SV40 latge T antigen are common sites for mutations, (1990) EMBO J. 9:1147-1155. |
Hunt, T., Maturation promoting factor, cyclin and the control of M-phase, (1989) Curr. Opinion Cell Biol. 1:268-274. |
Kaye et al., A single amino acid substitution results in a retinoblastoma protein defective in phosphorylation and oncoprotein binding, (1990) Proc. Natl. Acad. Sci. USA 87:6922-6926. |
Labbe et al., Purification of MPF from starfish: Identification as the H1 histone kinase p34.sup.cdc2 and a possible mechanism for its periodic activation, (1988) Cell 57:253-263. |
Lee et al., Cell cycle control genes in fission yeast and mammalian cells, (1988) Trends Genet. 4:287-90. |
Lew et al., Isolation of three novel human cyclins by rescue of G1 cyclin (Cln) function in yeast, (1991) Cell 66:1197-1206. |
Motokura et al., A novel cyclin encoded by a bc/1-linked candidate oncogene, (1991) Nature 350:512-515. |
Mundryi et al., Cell cycle regulation of the E2F transcription factor involves an interaction with cyclin A, (1991) Cell 65:1243-1253. |
Murray et al., The role of cyclin synthesis and degradation in the control maturation promoting factor activity, (1989) Nature 339:280-286. |
Nurse, Universial controlmechanism regulating onset of M-phase, (1990) Nature 344:503-508. |
Pines et al., Human cyclin A is adenovirus E1A-associated protein p60 and behaves differently from cyclin B, (1990) Nature 346:760-763. |
Pines et al., Isolation of a human cyclin cDNA: Evidence for cyclin mRNA and protein regulation in the cell cycle and for interactions with p34.sup.cdc2, (1989) Cell 58:833-846. |
Rosenblatt et al., Human cyclin-dependent kinase 2 is activated furing the S and G.sub.2 phases of the cell cycle and associated with cyclin A, (1992) Proc. Natl. Acad. Sci. USA 89:2824-2828. |
Serrano et al., A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4, (1993) Nature 366:704-707. |
Shirodkar et al., The transcription factor E2f interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner, (1992) Cell 68:157-166. |
Solomon et al., Cyclin activation of p34.sup.cdc2, (1990) Cell 63:1013-1024. |
Tsai et al., Isolation of the human cdk2 gene that encodes the cyclin A- and adenovirus E1A-associated p33 kinase, (1991) Nature 353:174-177. |
Wang et al., Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma, (1990) Nature 343:555-557. |
Whyte et al., Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product, (1988) Nature 334:124-129. |
Xiong et al., p21 is a universial inhibitor of cyclin kinases, (1993) Nature 366:701-704. |
Xiong et al., Subunit rearrangement of the cyclin-dependent kinases in associated with cellular transformation, (1993) Genes and Development7:1572-1583. |